Pharmacology of synaptic monoamine transmission.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000502:physiology; D005246:Feedback; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D010643:Phenoxybenzamine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D013116:Spinal Cord / Q000502:physiology; D013566:Sympathomimetics / Q000037:antagonists & inhibitors / Q000502:physiology*; D009435:Synaptic Transmission; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D010643:Phenoxybenzamine; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine